AssessmentsVaccinations: Clinical practice
USMLE® Step 1 style questions USMLE
USMLE® Step 2 style questions USMLE
A 36-year-old man comes to the clinic because of painful swelling and redness on his left arm. Yesterday afternoon, he received a tetanus booster injection in that area. The skin appears indurated, edematous, and dusky. His temperature is 37.1°C (98.8°F), pulse is 75/min, respirations are 13/min, and blood pressure 135/85 on the right arm. By the next morning, the lesion has subsided slightly. Which of the following is the most likely diagnosis?
Content Reviewers:Rishi Desai, MD, MPH
Vaccination is the process of generating a protective adaptive immune response against microbes by exposing the body to non-pathogenic forms of microbes or components of microbes.
Live attenuated vaccines contain pathogens that have been weakened in the laboratory and they’re used to protect against Measles, Mumps, Rubella, and Varicella - the MMR-V vaccine, Rotavirus, polio- the Oral Polio Vaccine or OPV, influenza- the nasal flu vaccine and Yellow fever.
Inactivated vaccines use a pathogen that has been killed in the laboratory and include vaccines against Hepatitis A, polio- the Inactivated Polio Vaccine or IPV, and Influenza- the inactivated influenza vaccine.
Subunit vaccines contain just a portion of the pathogens- like polysaccharides or proteins and this is done in vaccines against Haemophilus influenzae type B, Hepatitis B, human papillomavirus or HPV, Bordetella pertussis, Streptococcus pneumoniae, Neisseria meningitidis, and varicella zoster virus.
Finally, toxoid vaccines contain inactivated toxins produced by pathogens, and this is used in vaccines against Clostridium tetani which makes tetanus toxin and Corynebacterium diphtheriae which makes diphtheria toxin.
Toxoid vaccines are often combined with subunit vaccines to make a more immunogenic or strong vaccine. For example the TDaP and DTaP vaccine provides coverage against the toxins for tetanus and diphtheria, as well as the toxin and non-toxin antigens that are part of pertussis.
All of these vaccines can be administered one of four ways: intramuscularly, intradermally, subcutaneously, or orally.
One contraindication for all vaccines is having a severe allergic reactions like anaphylaxis when given a previous dose of vaccine or having that sort of reaction to any vaccine component. Another one is having a moderate or severe infection with or without fever, that doesn’t include having a mild upper respiratory tract infections.
Vaccines can also cause some side effects. For intramuscularly, intradermally, and subcutaneous injections, there can be pain, swelling, or redness at the injection site. There can be systemic symptoms like fever, malaise, headache, loss of appetite, and irritability. These typically start within 24 hours of the injection and improve over two days.
Now, in rare situations, so between one in 100,000 and one in a million, there can be more serious reactions. For example, more redness - spanning more than 3 inches or 7.5 cm at injection site, prolonged irritability, a fever above 104° F or 40° C, seizures, thrombocytopenia, or even anaphylaxis. With these rare situations, it’s sometimes hard to know if it was due to the vaccine itself or from something else.
In any case, even when accounting for these sorts of rare situations, the benefits from avoiding the diseases still far outweigh the risks from the vaccines.
Some strategies that decrease pain for infants are breastfeeding or giving sweet- tasting solutions during the vaccination procedure, distraction techniques and tactile stimulation, which means rubbing near the injection site prior and during the injection.
Then, for all children, optimizing the injection technique- for example, avoiding aspiration, which worsens pain, and ordering the vaccines so that the most painful one is administered last, also seems to help. Topical anesthetic creams, like 5% lidocaine, may also be applied to decrease pain.
Okay, now, let’s dive into the US vaccination schedule. We’ll start with the Hepatitis B vaccine. It’s a subunit vaccine against Hepatitis B virus, which is a major cause of hepatitis and liver cancer. It’s administered intramuscularly in a total of three doses.
The first dose is usually given immediately after birth and at least within 24 hours of birth, if the mother is negative for Hepatitis B surface antigen, or HbsAg, and the infant weighs more than 2000 grams. If the infant weighs less than 2000 grams at birth, then the first dose is given at 1 month of age. If the mother is positive for HbsAg, regardless of the infant’s birth weight, the first dose is given within 12 hours of birth, along with a dose of Hepatitis B immune globulin or HBIg for short. Now, if the mother’s HBsAg status is unknown, we once again give the vaccine within 12 hours of birth, regardless of birth weight. In infants weighing less than 2000 grams, this is given together with a dose of HBIg. But if the infant weighs more than 2000 grams, we go on to check for HBsAg and if it’s positive, we then administer a dose of HBIg within 7 days. In all cases, the second dose is given between 1 and 2 months of age and the third dose is given between 6 and 18 months.
There are two versions of the rotavirus vaccine, both of which are given orally: a monovalent one or RV1, which protects against a single virus strain and is given in two doses- at ages 2 and 4 months, and a pentavalent one or RV5, which protects against five viral strains and is given in three doses- at ages 2, 4, and 6 months.
Both of them are effective and safe. But since they’re live vaccines, they’re contraindicated in immunodeficient individuals. The vaccine carries a very low risk of intussusception, so it’s contraindicated in children with a history of intussusception.
Alright, now, the DTaP vaccine protects against diphtheria, which causes a severe form of pharyngitis that can cause airway obstruction, tetanus, which causes muscle spasms and respiratory arrest, and pertussis which causes apnea in infants and whooping cough in young children and adults.
DTaP is given intramuscularly in a total of 5 doses: at ages 2, 4, 6 months, and then at 15 to 18 months and finally, between 4 and 6 years. One dose of TdaP is given intramuscularly at the age of 11 to 12 years. After that, Td is given intramuscularly as a booster every 10 years.
Now, besides the routine childhood vaccination schedule, a person might need a Td booster or a Tetanus immunoglobulin, or TIG for short, or both of these, if they have a wound.
If an individual has received less than 3 tetanus toxoid doses from any vaccine over their lifetime, then TIG is given along with Td.
Individuals that have received at least 3 tetanus toxoid doses over their lifetime, regardless of how long ago, don’t need TIG, but may need Td.
If the wound is both clean and minor, and the last dose of tetanus toxoid was given over 10 years ago, then we give a Td booster.
If the wound is dirty, for example contaminated with dirt, feces, or saliva, no matter if it has been washed out, or severe, like a deep penetrating or puncture wound, and the last dose was given over 5 years ago, then we give a Td booster.
One contraindication to the DTaP and TdaP vaccines are signs of encephalopathy, like coma, altered level of consciousness, or seizures within 7 days of a previous vaccine dose. That’s because encephalopathy was associated with an older whole-cell pertussis vaccine preparation. Another contraindication is for individuals that developed Guillain-Barre syndrome within 6 weeks of a previous vaccine dose, because Guillain-Barre syndrome has been linked to the DTaP, TdaP and Td vaccines.
Next, there’s the Haemophilus influenzae type B or Hib vaccine which has virtually eradicated Haemophilus influenzae type B infections, which used to be a major cause of epiglottitis, pneumonia, and meningitis. It’s given intramuscularly in 4 doses: at 2, 4, 6, and 12 to 15 months. There are no specific contraindications.
There are two types: a 13-valent pneumococcal conjugate vaccine, or PCV13, which covers 13 different types of Streptococcus pneumoniae, and a pneumococcal polysaccharide vaccine, or PPSV23, which covers 23 different types.
PCV13 is given routinely in 4 doses: at 2, 4, 6, and 12 to 15 months.
And PPSV23 is given to children older than 2 years old with special medical conditions. Specifically, children with chronic heart or lung disease, diabetes mellitus, cerebrospinal fluid leaks, and cochlear implants, should receive a single dose of PPSV23, at least 8 weeks after the PCV13 series is complete.
Children with sickle cell disease or other hemoglobinopathies, congenital or acquired asplenia, or splenic dysfunction, HIV infection, chronic renal failure or nephrotic syndrome, congenital immunodeficiency or treatment with immunosuppressive drugs or radiation therapy should receive 2 doses of PPSV23, the first dose at least 8 weeks after the PCV13 series is complete, and a second dose at least 5 years later. There are no specific contraindications.